Related Experiment Video
Updated: Jul 14, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pharmacometrics at FDA: evolution and impact on decisions.
1Office of Translational Sciences, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA. robert.powell@fda.hhs.gov
Clinical Pharmacology and Therapeutics
|June 1, 2007
Summary
Drug development relies on complex data from trials and real-world use to ensure product quality and regulatory approval. Informed decisions enhance drug development efficiency and patient safety through clear labeling.
Area of Science:
- Pharmacology and Drug Development
- Regulatory Science
- Clinical Research
Background:
- Drug development and regulatory approval processes depend on comprehensive data.
- Information sources include clinical trials, supportive experiments, and post-market surveillance.
- The quality of regulatory decisions impacts drug development efficiency and product labeling.
Observation:
- Decisions in drug development, such as trial design and progression, are crucial.
- Regulatory bodies like the Food and Drug Administration (FDA) make product and labeling approval decisions.
- The information guiding these decisions is inherently complex and multifaceted.
Findings:
- Effective decision-making in drug development is directly linked to the quality and breadth of information utilized.
- Diverse data streams, from pre-clinical studies to post-market clinical experience, inform critical regulatory judgments.
- The complexity of information underscores the need for robust data integration and analysis.
Implications:
- Optimizing information synthesis is key to improving drug development timelines and regulatory efficiency.
- Enhanced decision-making frameworks can lead to higher quality drug products and clearer patient guidance (labeling).
- Understanding the complexity of data is vital for successful drug approval and post-market stewardship.
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...